PRLDPrelude Therapeutics Incorporated

CSNasdaq (XNAS)·USD

Identity

Security key: 20354
Ticker: PRLD
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2020-09-25
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PRLD

Detail

Enriched 2026-08-14 20:47

Market cap: $457,273,969.05
Shares outstanding (class): 79,645,307
Shares outstanding (weighted): 79,803,485
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 79
Location: WILMINGTON, DE
Homepage: https://www.preludetx.com
Description: Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $4.42M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$3.20M	0.00%	936,001 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$900.0K	0.00%	263,156 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$171.0K	0.14%	50,000 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$63.0K	0.00%	18,431 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$43.8K	0.00%	12,818 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$20.2K	0.00%	5,900 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$12.0K	0.00%	3,503 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$4.2K	0.00%	1,227 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPRLD
FIGI_COMPOSITEBBG00K7JY2Q6
FIGI_SHARE_CLASSBBG00K7JY2R5
CIK0001678660
ISINUS74065P1012
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a pharmaceutical preparation firm per SIC 2834, so it maps directly to EQUITY/HEALTHCARE/PHARMACEUTICALS.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.